Aclaris 制药 ACRS
$3.90 +$0.29 (+8.03%)
休市 · Nov 6, 10:00 pm ET · 最新盘后价 $3.90 0.00%
开盘$3.62
昨收$3.61
当日区间$3.61 – $3.98
成交量3.53M
市值$618.59M
市盈率（TTM）–
股息率–
财报
财报日平均波动±6.6%近16次财报
收涨次数4 / 1625% 的概率
最佳反应+20.4%
最差反应-10.2%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2024/Q1 | 7 May 2024 | After Market | ±35.1% | -8.96% | 符合区间 |
| 2023/Q1 | 8 May 2023 | Pre Market | ±12.5% | -6.46% | 符合区间 |
| 2019/Q4 | 25 Feb 2020 | None | – | -10.22% | – |
| 2019/Q3 | 7 Nov 2019 | After Market | – | +15.38% | – |
| 2019/Q2 | 8 Aug 2019 | After Market | – | -9.08% | – |
| 2019/Q1 | 8 May 2019 | After Market | – | -9.82% | – |
| 2018/Q4 | 18 Mar 2019 | Pre Market | – | +20.43% | – |
| 2018/Q3 | 6 Nov 2018 | After Market | – | +2.30% | – |
| 2018/Q2 | 3 Aug 2018 | Pre Market | – | -1.52% | – |
| 2018/Q1 | 8 May 2018 | After Market | – | -1.96% | – |
| 2017/Q4 | 12 Mar 2018 | None | – | -7.19% | – |
| 2017/Q3 | 7 Nov 2017 | Pre Market | – | -8.45% | – |
| 2017/Q2 | 8 Aug 2017 | Pre Market | – | -1.00% | – |
| 2017/Q1 | 9 May 2017 | Pre Market | – | -0.52% | – |
| 2016/Q4 | 15 Mar 2017 | Pre Market | – | +0.56% | – |
| 2016/Q3 | 3 Nov 2016 | Pre Market | – | -1.71% | – |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$1.63M-8.3% YoY
营业利润-$23.94M-41.6% YoY
净利润-$21.51M-39.4% YoY
摊薄每股收益-$0.15-15.4% YoY
自由现金流-$19.91M-116.8% YoY
经营现金流-$19.85M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率12.9%
营业利润率-1,040.4%
净利率-921.5%
净资产收益率-59.1%
资产收益率-41.1%
投入资本回报率-64.3%
流动比率3.46
负债/资产比率30.7%
现金及投资$91.56M
净现金（净负债）$91.56M
暂无评论——快来第一个聊聊 ACRS。
登录后参与讨论。